PRVA

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · derivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 160,990

Underlying: Common Stock, par value $0.01 per share · 154,676 shares

Expires 2033-08-27

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · nonDerivative · entry 2

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 11,998

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001759655-24-000123 · wk-form4_1724445147.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 12,487

F1 · kind: On August 21, 2024, the Reporting Person's spouse transferred her 49% interest in Emerald Family, LLC, which, immediately preceding the transfer, held 24,485 shares of Common Stock par value $0.01 of the Issuer, 315,666 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $2.00 and 182,283 stock options to purchase shares of Common Stock of the Issuer with an exercise price of $23.00, to a family trust ("Trust"). The Reporting Person and his children are the beneficiaries of the Trust. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001759655-24-000121 · wk-form4_1724444991.xml · nonDerivative · entry 2

McCarthy Thomas A · CIK 0001500886 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 41,487

F1 · kind: On August 21, 2024, the reporting person transferred 41,487 directly held shares of common stock of the Issuer to a family trust.

SEC source: 0001759655-24-000121 · wk-form4_1724444991.xml · nonDerivative · entry 1

McCarthy Thomas A · CIK 0001500886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,124

F1 · kind: On August 21, 2024, the reporting person transferred 41,487 directly held shares of common stock of the Issuer to a family trust.

SEC source: 0001759655-24-000108 · wk-form4_1718309106.xml · nonDerivative · entry 1

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,773,522

F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

SEC source: 0001759655-24-000103 · wk-form4_1717186379.xml · nonDerivative · entry 1

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,773,158

F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

SEC source: 0001759655-24-000100 · wk-form4_1717013286.xml · nonDerivative · entry 1

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,767,852

F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.42 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

SEC source: 0001759655-24-000094 · wk-form4_1716498401.xml · nonDerivative · entry 2

McCarthy Thomas A · CIK 0001500886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,611

SEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 3

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,763,572

F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

SEC source: 0001759655-24-000092 · wk-form4_1716498320.xml · nonDerivative · entry 1

Ryu Jaewon · CIK 0001869233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,251

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000096 · wk-form4_1716498470.xml · nonDerivative · entry 1

Maryland Patricia Anne · CIK 0001798468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,916

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000087 · wk-form4_1716498166.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,313

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000086 · wk-form4_1716498115.xml · nonDerivative · entry 1

COCOZZA NANCY G · CIK 0001232953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,955

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000095 · wk-form4_1716498439.xml · nonDerivative · entry 1

KING DAVID P · CIK 0001275654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,916

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant

SEC source: 0001759655-24-000094 · wk-form4_1716498401.xml · nonDerivative · entry 1

McCarthy Thomas A · CIK 0001500886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,611

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000093 · wk-form4_1716498346.xml · nonDerivative · entry 1

Kimmet Pamela O · CIK 0001589981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,313

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 2

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,590,930

F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

SEC source: 0001759655-24-000088 · wk-form4_1716498196.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,916

F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

SEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 1

Boehler Adam · CIK 0001982325 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,488,701

F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any

SEC source: 0001759655-24-000058 · wk-form4_1715630654.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,727

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000056 · wk-form4_1715630553.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,771

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000057 · wk-form4_1715630614.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · Former EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,356

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000042 · wk-form4_1714684750.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,101

F1 · kind: The sale reported in this Form 4 represents a mandatory, nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000045 · wk-form4_1714685104.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,959

F1 · kind: The sale reported in this Form 4 represents a mandatory, nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000044 · wk-form4_1714685050.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · Former EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,862

F1 · kind: The sale reported in this Form 4 represents a mandatory, nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000043 · wk-form4_1714685012.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,640

F1 · kind: The sale reported in this Form 4 represents a mandatory, nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

SEC source: 0001759655-24-000036 · wk-form4_1712262084.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,279

F1 · kind: The sale reported in this Form 4 represents a mandatory, nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2 · balance_after: On April 5, 2023, the Reporting Person filed a Form 4 ("Original Form 4") that inadvertently did not give effect to a correction in the number of shares of the issuer's common stock directly beneficially owned by the Reporting Person pursuant to a Form 4/A filed on December 20, 2022, which was 215,062 shares as of such date. The holdings reported on this Form 4 properly give cumulative effect to such correction in the Original Form 4 as well all intervening Forms 4 filed by the Reporting Person prior to the date hereof.

SEC source: 0001759655-24-000024 · wk-form4_1710276983.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,445,018

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.01 to $23.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-24-000024 · wk-form4_1710276983.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,445,418

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-24-000029 · wk-form4_1710536622.xml · nonDerivative · entry 1

Fargis Edward C · CIK 0002009323 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,948

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

SEC source: 0001759655-24-000033 · wk-form4_1710538842.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,596

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

SEC source: 0001759655-24-000031 · wk-form4_1710536865.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,859

F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. Additional Remarks

SEC source: 0001759655-24-000016 · wk-form4_1706736410.xml · nonDerivative · entry 1

Fargis Edward C · CIK 0002009323 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,404

F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest on the third anniversary of the grant date, generally subject to continued service through such date.

SEC source: 0001759655-24-000006 · wk-form4_1706304028.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,452,533

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.01 to $23.24 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-24-000006 · wk-form4_1706304028.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,464,533

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.01 to $23.11 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000222 · wk-form4_1703887725.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,474,484

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.80 to $24.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000220 · wk-form4_1703021002.xml · derivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 182,283

Underlying: Common Stock · 89,318 shares

Expires 2031-04-29

F1 · shares: Represents a gift of membership interests in Emerald Family, LLC to the reporting person's spouse, representing 49% of Emerald Family, LLC. The reporting person along with his spouse directly own all membership interests in Emerald Family, LLC.

F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock that were granted under the Issuer's 2021 Omnibus Incentive Plan. The 182,283 stock options reported in this transaction became exercisable on April 29, 2023.

F7 · balance_after: Includes 182,283 stock options previously owned directly by the reporting person which were contributed to Emerald Family, LLC, a limited liability company of which, at the time of transfer, the reporting person was the sole member and owned all of the LLC interests. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000220 · wk-form4_1703021002.xml · derivative · entry 3

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 315,666

Underlying: Common Stock, par value $0.01 per share · 154,676 shares

Expires 2033-08-27

F1 · shares: Represents a gift of membership interests in Emerald Family, LLC to the reporting person's spouse, representing 49% of Emerald Family, LLC. The reporting person along with his spouse directly own all membership interests in Emerald Family, LLC.

F3 · derivative.exercise_date: Reflects stock options to purchase shares of common stock that were granted under the Issuer's Second Amended and Restated PH Group Parent Corp. Stock Option Plan. The 315,666 stock options reported in this transaction became exercisable on October 29, 2022.

F4 · balance_after: Includes 315,666 stock options previously owned directly by the reporting person which were contributed to Emerald Family, LLC, a limited liability company of which, at the time of transfer, the reporting person was the sole member and owned all of the LLC interests. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000220 · wk-form4_1703021002.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Emerald Family, LLC

Disclosed balance after: 24,485

F1 · shares: Represents a gift of membership interests in Emerald Family, LLC to the reporting person's spouse, representing 49% of Emerald Family, LLC. The reporting person along with his spouse directly own all membership interests in Emerald Family, LLC.

F2 · balance_after: Includes 24,485 shares previously owned directly by the reporting person which were contributed to Emerald Family, LLC, a limited liability company of which, at the time of transfer, the reporting person was the sole member and owned all of the LLC interests. Mr. Morris disclaims beneficial ownership of the securities held by Emerald Family, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000218 · wk-form4_1702674410.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,486,484

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.78 to $24.22 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000218 · wk-form4_1702674410.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,498,484

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.01 to $23.14 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000202 · wk-form4_1695156017.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,510,484

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.89 to $25.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000202 · wk-form4_1695156017.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,523,404

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.87 to $24.83 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000200 · wk-form4_1694120909.xml · derivative · entry 5

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,667

Underlying: Common Stock · 3,333 shares

Expires 2035-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the transactions reported in this Form 4, 22,916 of the stock options were fully vested and exercisable. 2,084 of the stock options vest on September 8, 2023.

SEC source: 0001759655-23-000200 · wk-form4_1694120909.xml · derivative · entry 4

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,149

Underlying: Common Stock · 4,287 shares

Expires 2034-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000200 · wk-form4_1694120909.xml · derivative · entry 3

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,404

Underlying: Common Stock · 7,380 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000200 · wk-form4_1694120909.xml · nonDerivative · entry 2

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,114

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.54 to $25.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000200 · wk-form4_1694120909.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000198 · wk-form4_1694032018.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,528,637

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.18 to $26.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.